VEGF receptor 2 blockade leads to renal cyst formation in mice

S McGrath-Morrow1, C Cho, R Molls

  • 1Department of Pediatrics, Johns Hopkins University, Baltimore, Maryland 21287, USA. smorrow@jhmi.edu

Kidney International
|March 31, 2006
PubMed

Insights

Blocking vascular endothelial growth factor (VEGF) signaling in early life can cause kidney cysts. This disruption impacts kidney development, leading to polycystic kidney disease (PKD)-like symptoms.

Area of Science:

  • Nephrology
  • Developmental Biology
  • Vascular Biology

Background:

  • Polycystic kidney disease (PKD) involves genetic mutations and vascular abnormalities, but the link between epithelial and vascular defects is unclear.
  • Vascular endothelial growth factor (VEGF) is crucial for kidney development; its blockade in animal models causes glomerular abnormalities and renal failure.

Purpose of the Study:

  • To investigate if brief blockade of VEGF signaling during early postnatal kidney development can induce renal cyst formation.

Main Methods:

  • CD-1 mice were treated with antibodies against VEGF receptor 2 (DC101) on postnatal days 2 and 4.
  • Kidney development, cyst formation, cell proliferation, glomerular structure, and proteinuria were assessed in treated mice.

Main Results:

  • DC101-treated mice developed renal cysts between 2 and 3 weeks of age.
  • Increased renal tubule epithelium cell proliferation, abnormal glomeruli, proteinuria, and inflammation were observed.
  • Early disruption of VEGFR-2 signaling leads to renal cyst formation, impaired glomerulogenesis, and inflammation.

Conclusions:

  • VEGF signaling disruption during the perinatal period is a potential cause of renal cyst formation.
  • VEGF may serve as a critical link between vascular and cystic changes in kidney development.
  • This study highlights the role of VEGF in preventing cystogenesis and maintaining normal kidney structure.

Related Concept Videos